Dear Friends and Colleagues,
Strange Times – Difficult Decisions
After much consideration we have made the difficult but required decision in conjunction with the ESAO Executive Committee, to postpone ESAO 2020 to 2021 at Brunel University London.
Obviously, this is very disappointing, as we know how much ESAO annual conference means to everyone. We assure you this decision was not taken lightly or in haste, but we are still some distance from the peak of this dangerous pandemic and no date at sight to when might normal working conditions are restored. With lock-down in most countries, restrictions on movements and travel bans, we had no real choice, but to postpone.
We thank you and the whole ESAO membership for understanding the extreme difficulty of this decision and for your commitment to the success of ESAO yearly conference. Specifically, we profoundly appreciate all of the abstracts submitted, which we plan to publish in the International Journal of Artificial Organs, as originally planned (more information to the corresponding authors will be sent out next week).
In a spirit of optimism please mark September 2021 in your diaries. Meanwhile, take very good care of yourselves.
Yours sincerely with all good wishes,
Prof. Ashraf W Khir, Congress President, on behalf of the organising Committee.
Prof. Piotr Ladyzynski, ESAO President, on behalf of ESAO Executive Committee.
Uniting scientific minds towards lasting artificial organs
As a worldwide association, ESAO’s principal aims are the promotion of tissue and organ support and regeneration by artificial organ technology. Since its creation, the members of ESAO have been involved in the development of artificial organs. Some of these are now on the market, and often offer the patients a bridge to transplantation, when they are on a waiting list, or allow the efficient replacement of lost functions in acute or chronic organ failure.
With the progress of basic science, together with technology, these artificial organs will become smarter and smarter: miniaturisation, remote control, bio-hybrid systems will lead to incremental innovation or brand new devices, sometimes considered as “advanced therapies”. The translational research of our community ranges across cardiac assist devices, computer modelling, tissue engineering, bio measurements, artificial organs, drug delivery, bio-materials and stents.
All enquiries regarding this conference should be addressed to the Conference Secretariat:
The Conference Collective Ltd, 8 Waldegrave Road, Teddington, Middlesex, TW11 8HT, UK.
Tel: +44 (0) 20 8977 7997